Navigation Links
gloStream Announces Release of Microsoft-Based, Meaningful Use Certified gloEMR 6.0
Date:1/12/2011

TROY, Mich., Jan. 12, 2011 /PRNewswire/ -- gloStream, maker of gloEMR and gloPM – the only electronic medical record ("EMR") and practice management ("PM") software with Microsoft Office built right in – today announced the release of gloEMR 6.0., the sixth major upgrade to the gloEMR product line. Like its predecessor versions, gloEMR 6.0 leverages a variety of Microsoft technology such as the .NET platform, SQL Server and Microsoft Office so users have access to the most powerful and widely used technology available anywhere.

gloEMR offers a host of new features doctors can use to improve efficiency, productivity, and compliance with meaningful use criteria, which they must prove to collect Stimulus incentive funding.  This includes meaningful use and clinical quality measure dashboards that allow practice staff to track their compliance against all established criteria, in real time. In addition, the dashboards provide a mechanism for staff to pull data and report meaningful user status to the government, a key feature for all physicians seeking to acquire Stimulus funding.

"The tens of thousands of hours we've spent developing and testing gloEMR 6.0 have resulted in a product that is feature-rich, flexible and customizable to the specific needs of each practice we serve," said Piyush Khanna, gloStream's Chief Information Officer.  "gloEMR 6.0 provides doctors with important tools to ensure meaningful use compliance while also maximizing productivity via dashboards, personal health record integration, reporting and much, much more."

Additional, important key features within gloEMR include:

  • A fully customizable main dashboard homepage area.
  • HL7-standard Continuity of Care Documents ("CCDs") that can be sent and synched with other EMRs as well as personal health record applications such as Microsoft's HealthVault.
  • gloLabs Clearinghouse which provides access to more than 150 Labs.
  • Microsoft Reporting Services integration which offers the ability to create customizable reports based on clinical and financial information.
  • E&M coding and support for SNOMED.

gloEMR 6.0 was one of the very first EMRs to be ONC-ATCB 2011/2012 certified through the Certification Commission for Health Information Technology ("CCHIT").  As such, doctors using gloEMR 6.0 can be confident it contains all of the functionality needed for them to demonstrate meaningful use and collect their Stimulus payments.

About gloStream

gloStream provides physicians with certified, voice-enabled electronic medical record and practice management solutions delivered and supported through a nationwide community of local technology Partners.  gloStream products are secure, easy-to-use applications and the only solutions on the market with Microsoft Office built right in.  gloStream Partners leverage gloDNA ("gloStream Detailed Needs Analysis"), an innovative process that has given gloStream a 100 percent implementation success rate.  Every practice that has installed a gloStream application using gloDNA continues using it successfully today. For more information, visit glostream.com or call 877-456-3671.

gloEMR 6.0 from gloStream (CC-1112-501340-1), a complete EHR, is ONC-ATCB 2011/2012 compliant and has been certified by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable certification criteria for eligible providers adopted by the Secretary of Health and Human Services. gloEMR was certified on Sept 30, 2010, and has been certified for the following clinical quality measures: NQF 0421, NQF 0013, NQF 0028, NQF 0041, NQF 0024, NQF 0038, NQF 004, NQF, 0012, NQF 0032. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.


'/>"/>
SOURCE gloStream
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):